ArticleBlood advances2025

Overcoming venetoclax resistance through heme-mediated NOXA/cyclin D1/Mcl-1 axis with a novel artemisinin conjugate.

Jingyi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.